Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001371653 | SCV001568225 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 126 of the C9 protein (p.Gly126Arg). This variant is present in population databases (rs199939436, gnomAD 0.04%). This missense change has been observed in individual(s) with age-related macular degeneration (PMID: 29767720). ClinVar contains an entry for this variant (Variation ID: 1061985). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt C9 protein function. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on C9 function (PMID: 29767720). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV003992511 | SCV004810124 | uncertain significance | Complement component 9 deficiency | 2024-04-04 | criteria provided, single submitter | clinical testing |